Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Lanabecestat on the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel in Healthy Female Subjects

NCT03506399 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT03506399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03506399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Lanabecestat on the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel in Healthy Female Subjects
Lead sponsor
Eli Lilly and Company
Phase
Phase 1
Overall status
Withdrawn
Start date
June 30, 2018
Completion date
October 31, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy